Pentec Health Proplete® IDPN or IPN nutritional solutions provide patient-specific therapy designed to replenish protein losses that occur during dialysis treatments. Our renal clinical team specializes in the management of malnutrition for end-stage renal disease (ESRD) patients.
Our support goes beyond compounding therapies to help meet patients’ nutritional needs.
Our clinical team assists clinicians and physicians in supporting patients on IDPN or IPN therapy. They also monitor a patient’s response to therapy, identify ways to improve it, and complete quarterly reviews to measure a patient’s progress.
We provide educational information about the importance of protein during treatments so that clinicians can help educate the patient on the importance of their evolving nutrition needs and therapy.
Our intake team supports patients in understanding all aspects of the insurance and billing process and informs patients of their out-of-pocket expenses.
Pentec Health provides vital support for dialysis patients who struggle to meet protein requirements with food and supplements alone.
Even when counseled by experienced renal dietitians, many well-dialyzed patients consume approximately 80% or less of their recommended daily nutritional intake. Using our Proplete® IDPN or IPN therapies for renal nutrition could help your end-stage renal disease (ESRD) patients with the ability to meet nutrition goals and improve their quality of life.
More Info
Our Proplete® IDPN or IPN therapies are custom-prepared to specifically meet your nutritional needs. We regularly monitor your responses to treatments and suggest adjustments or changes as necessary. Our Clinical Case Managers and Pharmacists also offer behind-the-scenes support to optimize treatment outcomes.
More Info
How long a patient needs to receive IDPN/IPN depends on the severity of the malnutrition and why the malnutrition has occurred. A Renal Clinical Case Manager (RCCM) will monitor your patient’s progress closely through lab tests and other evaluations. The patient’s lab results will be reviewed at least quarterly, and more frequently if the clinician alerts the RCCM of a change in nutritional status. Typically, the goal of the IDPN therapy is to see an albumin level increase to 4.0g/dL. Once the albumin level has reached this goal, we will determine when the therapy can be discontinued. The RCCM might suggest to hold the therapy or take a “holiday” from it to see if the patient can maintain nutritional levels on his or her own. Each individual responds differently to the therapy, so the length of time therapy is administered will vary from patient to patient.
Dialysis patients have higher nutritional needs, especially protein. Some dialysis patients may not have a good appetite or find it difficult to tolerate or afford oral nutritional supplements. IDPN/IPN therapies can provide significant amounts of necessary protein without requiring you to drink or eat. Protein is essential for tissue repair and wound healing as well as protecting you against infections. Dialysis patients need approximately 50% more protein than people not receiving treatments.
Fill in this simple form for a prompt reply. You may also contact us directly.